Managing the practicalities of CAR T-cell therapies in patients with R/R MCL

Join haemato-oncologists with expertise in mantle cell lymphoma and CAR T-cell therapy as they respond to questions from the community oncology, haematology and haemato-oncology communities on current treatment strategies for relapsed or refractory mantle cell lymphoma and the role of CAR T-cell therapy
Watch now: touchhaematologyime.org/manag...
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.